Robert Delage - Concepedia

Author

Robert Delage

Université Laval

Also Known As

Delage R, Delage, R., R DELAGE, R DeLage, R Delage, R. Delage, R. Delage4, Raphael Delage, Robert Delage

114

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Université Laval Princess Margaret Cancer Centre McGill University Health Centre Hôpital du Saint-Sacrement CancerCare Manitoba

About

Robert Delage is an author at Université Laval specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	443
2	Health Sciences	1	1	11
3	Public Health	1	1	10
4	Biochemistry	1	1	34
5	Biomolecular Engineering	1	1	16

Robert Delage

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi, The Lancet Hematological MalignancyBone Marrow FailureMomelotinib Versus DanazolSymptomatic PatientsHematology	2023	164
The Impact of UGT1A8, UGT1A9, and UGT2B7 Genetic Polymorphisms on the Pharmacokinetic Profile of Mycophenolic Acid After a Single Oral Dose in Healthy Volunteers Éric Lévesque, Robert Delage, Marie‐Odile Benoit‐Biancamano, Clinical Pharmacology & Therapeutics	2007	158
Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia Robert Delage, RJ Soiffer, Keith Dear, Blood	1991	100
Anti-Erythropoietin Antibody-Mediated Pure Red Cell Aplasia after Treatment with Recombinant Erythropoietin Products Denis Cournoyer, Edwin B. Toffelmire, George A. Wells, Journal of the American Society of Nephrology ImmunologyBlood CellPathologyLikelihood EstimatesImmunotherapy	2004	77
Quantitative Analysis of Cytomegalovirus (CMV) Viremia Using the pp65 Antigenemia Assay and the COBAS AMPLICOR CMV MONITOR PCR Test after Blood and Marrow Allogeneic Transplantation Guy Boivin, Robert Bélanger, Robert Delage, Journal of Clinical Microbiology	2000	67
Overall survival in lower <scp>IPSS</scp> risk <scp>MDS</scp> by receipt of iron chelation therapy, adjusting for patient‐related factors and measuring from time of first red blood cell transfusion dependence: an <scp>MDS</scp>‐<scp>CAN</scp> analysis Heather A. Leitch, Ambica Parmar, Richard A. Wells, British Journal of Haematology	2017	61
Treatment of essential thrombocythemia during pregnancy with interferon-alpha. Robert Delage, C. Demers, Guy Cantin, PubMed	1996	57
T-cell-depleted autologous bone marrow transplantation therapy: analysis of immune deficiency and late complications KC Anderson, RJ Soiffer, Robert Delage, Blood	1990	50
T-cell-depleted autologous bone marrow transplantation therapy: analysis of immune deficiency and late complications KC Anderson, RJ Soiffer, Robert Delage, Blood	1990	47
Pharmacokinetics of Mycophenolate Mofetil and its Glucuronide Metabolites in Healthy Volunteers Éric Lévesque, Marie‐Odile Benoit‐Biancamano, Robert Delage, Pharmacogenomics	2008	43

Page 1